Published

Psychedelic Drug Checking: Analytical and Strategic Challenges in Harm Reduction for Classic Psychedelics.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Current topics in behavioral neurosciences
Date: 2026-01-01
Source: PubMed
DOI: 10.1007/7854_2025_606
PubMed: 41087826

Authors

Hirschfeld T Blei F Stegemann L van der Gouwe D Smit-Rigter L

Watch author

Derived topics and classifications

psilocybin Safety Other

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Retreat from racism: A psychedelic group experience for racial stress and traumaPsychedelics · 2026-07-30 Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping reviewPsychedelics · 2026-07-26 Gregor Hasler: Three Guiding Questions - How do psychedelics shape the brain? How can they heal psychiatric disorders such as depression and PTSD? How can we ensure their safe and responsible use?Psychedelics. · 2025-09-02 Psychedelic treatment for anorexia nervosa: A first-hand view of how psilocybin treatment did and did not helpPsychedelics. · 2024-11-07 Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery modelPsychedelics · 2026-12-01 Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexiaPsychedelics. · 2026-02-03 Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experiencePsychedelics · 2025-11-20 Interactions between psilocybin, LSD, and serotonergic antidepressants: A qualitative analysis of user reportsPsychedelics · 2025-11-20